Nootropic Research Peptides in Bali

Semax and Selank were both developed in Russia and share a research history that stretches back decades, distinct from the more recent Western literature that exists on many other research peptides. Semax is derived from a fragment of adrenocorticotropic hormone, and Selank is a synthetic analogue built on a tuftsin related peptide sequence, studied for a calming rather than a stimulating profile in the published literature.

Semax research includes both animal studies and small Russian clinical studies. A 2017 rat study by Medvedeva and colleagues in Molecular Genetics and Genomics looked at gene expression changes in the brain during ischemic injury following Semax administration. Separately, a 2018 clinical study by Gusev and colleagues, published in the Zhurnal Nevrologii i Psikhiatrii, examined Semax in patients at different stages of ischemic stroke, a small clinical study conducted in Russia rather than a large international trial.

Selank research

Selank has a similar pattern of evidence behind it. An early mechanistic study by Zozulya and colleagues in 2001, in the Bulletin of Experimental Biology and Medicine, looked at how Selank inhibits enkephalin degrading enzymes as a possible explanation for its studied anxiolytic activity in animal models. A separate small clinical study, published in 2008 in the Zhurnal Nevrologii i Psikhiatrii, examined Selank in patients with generalized anxiety disorder and neurasthenia, again a Russian clinical study rather than a large randomised international trial.

Dihexa: animal research only

Dihexa is a more recent compound, studied as a stabilised analogue in the angiotensin IV research family and described in the literature as a potent HGF mimetic. The evidence base here is entirely preclinical so far. A 2013 study by McCoy and colleagues in the Journal of Pharmacology and Experimental Therapeutics evaluated Dihexa and related angiotensin IV analogs as procognitive candidates in animal models, and later research has stayed in that same animal study territory rather than moving into human trials.

Nasal solutions, vials and storage

Nootropic peptides in Bali are supplied here as lyophilised vials or, where available, as research nasal sprays, as this page describes. Vials need reconstituting with bacteriostatic water, which allows flexible measuring for a research protocol, while the nasal spray format is ready to use straight away without that preparation step.

Before use, keep these compounds cool and out of direct light. Once a vial is reconstituted, refrigerate it and use it within the compound's usual stability window, and keep opened nasal spray formats refrigerated as well rather than left at room temperature between sessions.